<?xml version="1.0" encoding="UTF-8"?>
<p>Recombinant human interferon-α (rHuIFN-α) has antiviral and immune-modulatory activity. IFN-α is active against many DNA and RNA viruses [
 <xref rid="B98-vetsci-02-00456" ref-type="bibr">98</xref>]. There are two common treatment regimens for use of rHuIFN-α in cats: SC injection (10
 <sup>4</sup> to 10
 <sup>6</sup> U/kg every 24 h) or oral application (1 to 50 U/kg every 24 h). 
</p>
